Month: January 2021

Those who are bearish on BlackBerry (NYSE:BB) — including the many people who are short-selling the name — continue to vastly underestimate how much money the company can make. That’s because BlackBerry’s cybersecurity business is bolstering BB stock, with more upside on the horizon from connected vehicles and more. Basically, cybersecurity threats are becoming more
0 Comments
Companies like Electrameccanica Vehicles (NASDAQ:SOLO) are trying to ride on Tesla’s (NASDAQ:TSLA) coattails with their electric vehicles (EVs). However, SOLO shares have cratered from their 52-week high of $13.60 per share down to single digits. Nevertheless, the stock remains highly inflated. Competition in the broader EV space is heating up. And even though Electrameccanica has a
0 Comments
The Robinhood website home screen on a smartphone. Gabby Jones | Bloomberg | Getty Images Restrictions on Robinhood traders are still tight and getting tighter throughout the day on Friday, now only allowing GameStop holders to buy a single additional share. The stock trading app has also expanded its list of restricted stocks from 13
0 Comments
AT&T (NYSE:T) bought DirecTv and Time Warner in the last decade, after becoming convinced that just moving bits was a bad business. Now, with 5G and the promise of the Machine Internet, bits are becoming a very good business. The question is whether T stock can make the turn. Source: Jonathan Weiss/Shutterstock AT&T opened for
0 Comments
The Reddit forum WallStreetBets logo on a smartphone arranged in Sydney, Australia, on Thursday, Jan. 28, 2021. Brent Lewin | Bloomberg | Getty Images What’s next for the Reddit crowd? Wall Street seems unsure.  The “blow-out-the-short-sellers game” is showing signs of exhaustion, but the ramifications are only just being felt. What traders can’t agree on is
0 Comments
Take a look at some of the biggest movers in the premarket: Biogen (BIIB) – The drugmaker’s shares jumped nearly 12% premarket on news that the Food and Drug Administration has extended the review period by three months for its experimental Alzheimer’s treatment aducanumab. Biogen is providing additional data to the FDA as part of
0 Comments
Robinhood CEO Vlad Tenev said Robinhood’s move to stop trading in certain speculative names was in the best interest of the company and its millions of users. “In order to protect the firm and protect our customers we had to limit buying in these stocks,” Tenev told CNBC’s Andrew Ross Sorkin Thursday evening. “Robinhood is
0 Comments